Wrap Technologies, Inc. 2025 Annual Report: Key Highlights and Investor Insights

Overview

Wrap Technologies, Inc. (“Wrap”) filed its annual report for the fiscal year ended December 31, 2025. The company, headquartered in Miami, FL, is listed on the Nasdaq Capital Market under the symbol “WRAP” and operates primarily in the ordnance and accessories segment, focusing on innovative non-lethal public safety solutions.

Key Financial and Corporate Highlights

• Market Capitalization: As of June 30, 2025, Wrap’s aggregate market value held by non-affiliates was \$79,136,515, based on a closing share price of \$1.56.
• Shares Outstanding: As of March 23, 2026, the company had 55,500,054 shares of common stock outstanding.
• Shareholder Base: Approximately 37 stockholders of record.
• Nasdaq Listing: The company is listed on Nasdaq Capital Market, but faces risks relating to continued compliance with Nasdaq listing standards.

Business Focus and Product Lines

• BolaWrap Product Line: Wrap is heavily reliant on sales of its BolaWrap product, a non-lethal restraining device classified as a firearm and regulated by the ATF. The company expects this product to remain central to its revenue and growth prospects for the foreseeable future.
• Wrap Reality VR Training Platform: The company is investing in commercializing its Wrap Reality VR training platform, targeting a competitive market for law enforcement and public safety training.
• Other Brands and Trademarks: Wrap also owns trademarks such as Intrensic, Evidence on a Cloud, WrapVision, WrapTactics, Non-Lethal Response, and DFR-X.

Potential Price-Sensitive Risks and Issues for Shareholders

Financial Risks

• History of Operating Losses: Wrap has a history of operating losses and warns it may never achieve or sustain profitability. This is critical for investors, as continued losses may require raising additional capital, which could dilute existing shareholders.
• Capital Requirements: The company may need to raise additional capital through equity or debt. Issuing new shares or convertible debt could cause significant dilution and may come with restrictive covenants.
• Expense Volatility: Quarterly results may vary due to fluctuations in R&D, marketing, IP protection, hiring, and supply chain costs. Most operating expenses are relatively fixed in the short term, making it difficult to adjust quickly to sales shortfalls.
• Preferred Stock Dilution: Wrap’s Series A Convertible Preferred Stock contains anti-dilution and dividend provisions that can cause dilution to holders of common stock. There are also covenants that may restrict further financing.

Operational and Strategic Risks

• Heavy Reliance on BolaWrap: If the BolaWrap product fails to achieve broad market acceptance, Wrap’s growth prospects would be severely impacted.
• Competitive Pressure: The market is highly competitive. Larger, better-capitalized competitors may be able to outspend Wrap in R&D, marketing, IP litigation, and commercialization.
• Regulatory Risks: The evolving regulatory framework for AI technologies and firearms could increase compliance costs and affect product deployment.
• International Risks: Wrap’s international operations expose it to risks such as currency fluctuations, export controls, lengthy shipping times, and geopolitical instability.
• Reputation Risks: Negative media coverage regarding the effectiveness or appropriateness of Wrap’s non-lethal solutions could adversely affect sales and financial results.

Intellectual Property Risks

• IP Protection: Wrap’s patents and intellectual property may not adequately protect its products from competition. The company faces potential litigation from third parties claiming infringement, which could be costly and divert management’s attention.
• Trade Secrets: The risk of unauthorized disclosure of trade secrets and proprietary information remains a concern.

Stock-Related Risks

• Volatility: The market price of Wrap’s common stock has been and may continue to be highly volatile, driven by actual or anticipated fluctuations in operating results, analyst coverage, technical innovations, and broader market trends.
• Securities Litigation: Wrap has been, and may in the future be, subject to securities litigation. Such lawsuits can be costly and distract management from core business activities.
• Nasdaq Compliance: Failure to meet Nasdaq’s continued listing requirements could result in delisting, which would materially reduce liquidity, limit capital-raising options, and potentially lower share price.
• Dilution Risks: Additional issuances of common or preferred stock, including from the exercise of options, warrants, or restricted stock units, could dilute existing shareholders and depress the share price.
• Insider Ownership: Management and certain directors owned more than 10% of common stock as of December 31, 2025, giving them significant influence over shareholder votes.
• No Dividends: Wrap has never declared dividends on common stock and does not anticipate doing so. Series A Preferred Stockholders must consent before any dividends are paid to common shareholders.

General Corporate Risks

• Public Company Costs: Wrap incurs substantial costs as a public company, including compliance with Sarbanes-Oxley, Dodd-Frank, and exchange listing rules, which may divert resources from revenue-generating activities.
• Internal Controls: The company acknowledges that its disclosure controls and internal controls have inherent limitations and may not prevent all acts of fraud. Maintaining effective internal controls is necessary for reliable financial reporting; any failure could harm investor confidence and the share price.

Cybersecurity and Compliance

Wrap maintains a comprehensive process for managing cybersecurity threats but recognizes risks remain. Regulatory changes or adverse events in this area could affect operations and share value.

Recent Developments

• Warrants Offering: In February 2026, Wrap issued Common Warrants exercisable at \$2.30 per share (expiring five years from issuance) and Pre-Funded Warrants exercisable immediately. Such offerings may dilute existing shareholders and affect share value.
• No Unregistered Securities: No unregistered securities were issued during 2025 that were not previously disclosed.

Conclusion: What Investors Must Watch

Investors should closely monitor Wrap’s ability to achieve profitability, maintain compliance with Nasdaq listing requirements, manage dilution risks, and defend its intellectual property. The company’s heavy reliance on the BolaWrap product line and potential for further capital raises are significant factors that could materially impact share price in the near and medium term. Additionally, sustained operating losses, volatility in expenses, and the risk of securities litigation or regulatory challenges pose ongoing threats to shareholder value.

Disclaimer

This article is based on Wrap Technologies, Inc.’s 2025 Annual Report and is for informational purposes only. It does not constitute investment advice or a solicitation to buy or sell securities. Investors should conduct their own research and consult with a financial advisor before making investment decisions. The information presented may be subject to change and is not guaranteed for accuracy or completeness.

View WRAP TECHNOLOGIES, INC. Historical chart here